Search for a report

Reports

  • You are here:
  • Home
  • Downloads
  • GLOBAL BIOSURGERY MARKET FORECAST 2021-2028

GLOBAL BIOSURGERY MARKET FORECAST 2021-2028

The global biosurgery market is anticipated to register a CAGR of 6.32% and generate a revenue of $15513.0 million by 2028. The base year considered for the market study is 2020, and the forecast period is from 2021 to 2028.

GLOBAL BIOSURGERY MARKET FORECAST 2021-2028

Global Biosurgery Market by Product ( Hemostatic Agents, Bone-graft Substitutes ( Synthetic Graft Extenders, Demineralized Bone Matrix, Bone Morphogenetic Proteins, Cell-based Matrices ) Surgical Sealing Agents ( Natural, Synthetic ) Soft-tissue Management ( Synthetic Mesh/patch, Natural Mesh/patch ) Anti-adhesive Agents, Staple Line Reinforcement ) Market by Source Type ( Natural, Synthetic ) Market by Application ( Orthopedic Surgery, Cardio and Thoracic Surgery, Neuro and Spine Surgery, General Surgery, Other Applications ) by Geography.

Request free sample

The global biosurgery market is anticipated to register a CAGR of 6.32% and generate a revenue of $15513.0 million by 2028. The base year considered for the market study is 2020, and the forecast period is from 2021 to 2028.biosurgery-market

To learn more about this report, request a free sample copy

The global biosurgery market has gained prominence owing to the surge in chronic disorders, an aging population across the world, and the rising healthcare expenditure. Moreover, the adoption of bio surgical products is high due to the increase in the obese and overweight population.

Key factors propelling the global biosurgery market growth:

  • Prevalence of geriatric population
    • The growing geriatric population has more health issues compared to younger individuals.
    • More than 80% of fractures in people aged over 50 years are majorly caused by osteoporosis. Bone fractures are common orthopedic problems in the elderly population due to the weakening of bones.
  • Advancements in technology
  • Incidence of musculoskeletal disorders
  • Surge in research and development

Major growth restraining factors:

  • High cost of surgeries
  • Risk associated with immune response
  • Growing popularity of minimally invasive procedures
    • Minimally invasive surgeries provide more targeted treatment and cause less damage to the surrounding healthy tissues.
    • As a lower number of foreign instruments are introduced during the procedure, minimally invasive surgery also has a reduced effect on the host’s immune system.

The report scope of the global biosurgery market includes segmentation analysis based on product, source type, and application.

Market by Application:

  • Orthopedic Surgery
  • Orthopedic surgery dominated the application category in 2020.
  • The rise in musculoskeletal diagnoses and osteoporosis-associated fractures drives the demand for orthopedic operations among the populace aged 65 years or older.
  • Moreover, biological products have numerous applications in orthopedic surgeries.
  • Neuro and Spine Surgery
  • Neuro and spine surgery is the fastest-growing application.
  • Biosurgical hemostatic agents have proved extremely effective in neurosurgical procedures in order to complete the more traditional use of electrocoagulation.
  • Several biosurgical topical hemostatic agents have been developed over recent years for the same.
  • General Surgery
  • Cardio and Thoracic Surgery
  • Other Applications

Geographically, the global biosurgery market has been segmented based on four major regions, which includes:

  • North America: The United States and Canada
    • North America held the highest market share in 2020.
    • Key factors such as the rising incidence of chronic diseases, including cardiovascular conditions, the aging population, and the rapid acceptance of technological advancements fuel the region’s market growth.
    • In addition, the increasing government funding and investment further contribute to North America’s significant share.
  • Europe: Germany, Belgium, France, the United Kingdom, Italy, Russia, Poland, and Rest of Europe
  • Asia-Pacific: India, Australia & New Zealand, China, South Korea, Japan, Thailand, Indonesia, Vietnam, and Rest of Asia-Pacific
    • Asia-Pacific is set to lead the global market by 2028.
    • Key drivers such as the growing burden of chronic disorders, the rising number of surgical procedures, and the development of new products are expected to drive the Asia-Pacific biosurgery market.
    • Moreover, an increase in the number of research laboratories for R&D purposes is anticipated to augment the demand for biosurgery products since new products will be introduced into the market.
  • Rest of World: Latin America, the Middle East & Africa

Major market players operating in the global biosurgery market:

  • Baxter International Inc
  • Becton, Dickinson and Company
  • Medtronic PLC
  • Sanofi
  • Stryker Corporation
  • Others

Key strategies adopted by some of these companies:

In June 2020, Becton, Dickinson and Company acquired Straub Medical AG, a privately-held corporation that sells and develops medical thrombectomy devices and atherectomy.

Key findings of the global biosurgery market:

  • A surge in the overweight population plays a key role in driving the global market growth.
  • The growing disposable income provides the global market with lucrative expansion opportunities.

 

Frequently Asked Questions (FAQs):

  • What is the scope of the global biosurgery market in the future?

A: Currently, the global biosurgery market is revolutionizing treatment therapeutics for various diseases. The global market is also in a rigorous developmental phase due to the rising number of biosurgical procedures. Hence, with various research activities underway, the market is expected to witness tremendous growth opportunities over the upcoming years.

  • How will the COVID-19 pandemic affect market growth?

A: The market observed a decline in both elective and emergence surgeries due to the COVID-19 pandemic. As a result, the demand for upper limb prosthetics was restrained, thereby negatively impacting the market growth.

  • How does the surging elderly population fuel the global biosurgery market?

A: A rise in the elderly population has led to a steep increase in the number of chronic diseases, like cardiovascular and neurological disorders, including Parkinson’s disease, Alzheimer’s disease, and others. Brain grafting is the most widely adopted treatment procedure for Parkinson’s. Thus, the increasing aging population is set to propel the demand for this treatment procedure.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • KEY DRIVERS
      • PREVALENCE OF GERIATRIC POPULATION
      • ADVANCEMENTS IN TECHNOLOGY
      • INCIDENCE OF MUSCULOSKELETAL DISORDERS
      • SURGE IN RESEARCH AND DEVELOPMENT
    • KEY RESTRAINTS
      • HIGH COST OF SURGERIES
      • RISK ASSOCIATED WITH IMMUNE RESPONSE
      • GROWING POPULARITY OF MINIMALLY INVASIVE PROCEDURES
  1. KEY ANALYTICS
    • IMPACT OF COVID-19 ON BIOSURGERY MARKET
    • KEY MARKET TRENDS
    • PORTER’S FIVE FORCES ANALYSIS
      • BUYERS POWER
      • SUPPLIERS POWER
      • SUBSTITUTION
      • NEW ENTRY
      • INDUSTRY RIVALRY
    • KEY BUYING CRITERIA
    • KEY INSIGHTS
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
  2. MARKET BY PRODUCT
    • HEMOSTATIC AGENTS
    • BONE-GRAFT SUBSTITUTES
      • SYNTHETIC GRAFT EXTENDERS
      • DEMINERALIZED BONE MATRIX
      • BONE MORPHOGENETIC PROTEINS
      • CELL-BASED MATRICES
    • SURGICAL SEALING AGENTS
      • NATURAL
      • SYNTHETIC
    • SOFT-TISSUE MANAGEMENT
      • SYNTHETIC MESH/PATCH
      • NATURAL MESH/PATCH
    • ANTI-ADHESIVE AGENTS
    • STAPLE LINE REINFORCEMENT
  3. MARKET BY SOURCE TYPE
    • NATURAL
    • SYNTHETIC
  4. MARKET BY APPLICATION
    • ORTHOPEDIC SURGERY
    • CARDIO AND THORACIC SURGERY
    • NEURO AND SPINE SURGERY
    • GENERAL SURGERY
    • OTHER APPLICATIONS
  5. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • GERMANY
        • UNITED KINGDOM
        • FRANCE
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • AUSTRALIA & NEW ZEALAND
        • SOUTH KOREA
        • THAILAND
        • INDONESIA
        • VIETNAM
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • KEY STRATEGIC DEVELOPMENTS
      • MERGERS & ACQUISITIONS
      • PRODUCT LAUNCHES & DEVELOPMENTS
      • PARTNERSHIPS & AGREEMENTS
      • BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
    • COMPANY PROFILES
      • BAXTER INTERNATIONAL INC
      • B BRAUN MELSUNGEN AG
      • BECTON, DICKINSON AND COMPANY (C R BARD)
      • BETATECH MEDICAL
      • CSL LIMITED
      • CRYOLIFE INC
      • ETHICON INC (JOHNSON & JOHNSON)
      • INTEGRA LIFESCIENCES HOLDINGS CORPORATION
      • MEDTRONIC PLC
      • RTI SURGICAL
      • SANOFI
      • SMITH & NEPHEW PLC
      • STRYKER CORPORATION
      • WRIGHT MEDICAL GROUP NV
      • ZIMMER BIOMET HOLDINGS INC

 

TABLE LIST

TABLE 1: MARKET SNAPSHOT – BIOSURGERY

TABLE 2: AGING POPULATION AROUND THE WORLD 2019 & 2050

TABLE 3: GLOBAL BIOSURGERY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 4: GLOBAL BIOSURGERY MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 5: GLOBAL HEMOSTATIC AGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 6: GLOBAL HEMOSTATIC AGENTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 7: GLOBAL BONE-GRAFT SUBSTITUTES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 8: GLOBAL BONE-GRAFT SUBSTITUTES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 9: GLOBAL BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 10: GLOBAL BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 11: GLOBAL SYNTHETIC GRAFT EXTENDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 12: GLOBAL SYNTHETIC GRAFT EXTENDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 13: GLOBAL DEMINERALIZED BONE MATRIX MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 14: GLOBAL DEMINERALIZED BONE MATRIX MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 15: GLOBAL BONE MORPHOGENETIC PROTEINS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 16: GLOBAL BONE MORPHOGENETIC PROTEINS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 17: GLOBAL CELL-BASED MATRICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 18: GLOBAL CELL-BASED MATRICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 19: GLOBAL SURGICAL SEALING AGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 20: GLOBAL SURGICAL SEALING AGENTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 21: GLOBAL SURGICAL SEALING AGENTS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 22: GLOBAL SURGICAL SEALING AGENTS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 23: GLOBAL NATURAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 24: GLOBAL NATURAL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 25: GLOBAL SYNTHETIC MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 26: GLOBAL SYNTHETIC MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 27: GLOBAL SOFT-TISSUE MANAGEMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 28: GLOBAL SOFT-TISSUE MANAGEMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 29: GLOBAL SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 30: GLOBAL SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 31: GLOBAL SYNTHETIC MESH MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 32: GLOBAL SYNTHETIC MESH MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 33: GLOBAL NATURAL MESH MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 34: GLOBAL NATURAL MESH MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 35: GLOBAL ANTI-ADHESIVE AGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 36: GLOBAL ANTI-ADHESIVE AGENTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 37: GLOBAL STAPLE LINE REINFORCEMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 38: GLOBAL STAPLE LINE REINFORCEMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 39: GLOBAL BIOSURGERY MARKET, BY SOURCE TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 40: GLOBAL BIOSURGERY MARKET, BY SOURCE TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 41: GLOBAL NATURAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 42: GLOBAL NATURAL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 43: GLOBAL SYNTHETIC MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 44: GLOBAL SYNTHETIC MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 45: GLOBAL BIOSURGERY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 46: GLOBAL BIOSURGERY MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 47: GLOBAL ORTHOPEDIC SURGERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 48: GLOBAL ORTHOPEDIC SURGERY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 49: GLOBAL CARDIO AND THORACIC SURGERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 50: GLOBAL CARDIO AND THORACIC SURGERY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 51: GLOBAL NEURO AND SPINE SURGERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 52: GLOBAL NEURO AND SPINE SURGERY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 53: GLOBAL GENERAL SURGERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 54: GLOBAL GENERAL SURGERY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 55: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 56: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 57: GLOBAL BIOSURGERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 58: GLOBAL BIOSURGERY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 59: NORTH AMERICA BIOSURGERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 60: NORTH AMERICA BIOSURGERY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 61: LEADING PLAYERS OPERATING IN NORTH AMERICA BIOSURGERY MARKET

TABLE 62: EUROPE BIOSURGERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 63: EUROPE BIOSURGERY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 64: LEADING PLAYERS OPERATING IN EUROPE BIOSURGERY MARKET

TABLE 65: ASIA-PACIFIC BIOSURGERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 66: ASIA-PACIFIC BIOSURGERY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 67: LEADING PLAYERS OPERATING IN THE ASIA-PACIFIC BIOSURGERY MARKET

TABLE 68: REST OF WORLD BIOSURGERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 69: REST OF WORLD BIOSURGERY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 70: LEADING PLAYERS OPERATING IN REST OF WORLD BIOSURGERY MARKET

TABLE 71: LIST OF MERGERS & ACQUISITIONS

TABLE 72: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 73: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 74: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES           

FIGURE LIST

FIGURE 1: PORTER’S FIVE FORCES ANALYSIS

FIGURE 2: KEY MARKET TRENDS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: GLOBAL BIOSURGERY MARKET, BY PRODUCT, IN 2020

FIGURE 6: GLOBAL BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2021-2028 (IN $ MILLION)

FIGURE 7: GLOBAL BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2021-2028 (IN $ MILLION)

FIGURE 8: GLOBAL BONE-GRAFT SUBSTITUTES MARKET, BY SYNTHETIC GRAFT EXTENDERS, 2021-2028 (IN $ MILLION)

FIGURE 9: GLOBAL BONE-GRAFT SUBSTITUTES MARKET, BY DEMINERALIZED BONE MATRIX, 2021-2028 (IN $ MILLION)

FIGURE 10: GLOBAL BONE-GRAFT SUBSTITUTES MARKET, BY BONE MORPHOGENETIC PROTEINS, 2021-2028 (IN $ MILLION)

FIGURE 11: GLOBAL BONE-GRAFT SUBSTITUTES MARKET, BY CELL-BASED MATRICES, 2021-2028 (IN $ MILLION)

FIGURE 12: GLOBAL BIOSURGERY MARKET, BY SURGICAL SEALING AGENTS, 2021-2028 (IN $ MILLION)

FIGURE 13: GLOBAL SURGICAL SEALING AGENTS MARKET, BY NATURAL, 2021-2028 (IN $ MILLION)

FIGURE 14: GLOBAL SURGICAL SEALING AGENTS MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)

FIGURE 15: GLOBAL BIOSURGERY MARKET, BY SOFT-TISSUE MANAGEMENT, 2021-2028 (IN $ MILLION)

FIGURE 16: GLOBAL SOFT-TISSUE MANAGEMENT MARKET, BY SYNTHETIC MESH/PATCH, 2021-2028 (IN $ MILLION)

FIGURE 17: GLOBAL SOFT-TISSUE MANAGEMENT MARKET, BY NATURAL MESH/PATCH, 2021-2028 (IN $ MILLION)

FIGURE 18: GLOBAL BIOSURGERY MARKET, BY ANTI-ADHESIVE AGENTS, 2021-2028 (IN $ MILLION)

FIGURE 19: GLOBAL BIOSURGERY MARKET, BY STAPLE LINE REINFORCEMENT, 2021-2028 (IN $ MILLION)

FIGURE 20: GLOBAL BIOSURGERY MARKET, BY SOURCE TYPE, IN 2020

FIGURE 21: GLOBAL BIOSURGERY MARKET, BY NATURAL, 2021-2028 (IN $ MILLION)

FIGURE 22: GLOBAL BIOSURGERY MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)

FIGURE 23: GLOBAL BIOSURGERY MARKET, BY APPLICATION, IN 2020

FIGURE 24: GLOBAL BIOSURGERY MARKET, BY ORTHOPEDIC SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 25: GLOBAL BIOSURGERY MARKET, BY CARDIO AND THORACIC SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 26: GLOBAL BIOSURGERY MARKET, BY NEURO AND SPINE SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 27: GLOBAL BIOSURGERY MARKET, BY GENERAL SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 28: GLOBAL BIOSURGERY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 29: NORTH AMERICA BIOSURGERY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 30: UNITED STATES BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 31: CANADA BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 32: EUROPE BIOSURGERY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 33: GERMANY BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 34: UNITED KINGDOM BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 35: FRANCE BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 36: ITALY BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 37: RUSSIA BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 38: BELGIUM BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 39: POLAND BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 40: REST OF EUROPE BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 41: ASIA-PACIFIC BIOSURGERY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 42: CHINA BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 43: JAPAN BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 44: INDIA BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 45: AUSTRALIA & NEW ZEALAND BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 46: SOUTH KOREA BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 47: THAILAND BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 48: INDONESIA BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 49: VIETNAM BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 50: REST OF ASIA-PACIFIC BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 51: REST OF WORLD BIOSURGERY MARKET, BY REGION, 2020 & 2028 (IN %)

FIGURE 52: LATIN AMERICA BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 53: MIDDLE EAST & AFRICA BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

  1. MARKET BY PRODUCT
    • HEMOSTATIC AGENTS
    • BONE-GRAFT SUBSTITUTES
      • SYNTHETIC GRAFT EXTENDERS
      • DEMINERALIZED BONE MATRIX
      • BONE MORPHOGENETIC PROTEINS
      • CELL-BASED MATRICES
    • SURGICAL SEALING AGENTS
      • NATURAL
      • SYNTHETIC
    • SOFT-TISSUE MANAGEMENT
      • SYNTHETIC MESH/PATCH
      • NATURAL MESH/PATCH
    • ANTI-ADHESIVE AGENTS
    • STAPLE LINE REINFORCEMENT
  2. MARKET BY SOURCE TYPE
    • NATURAL
    • SYNTHETIC
  3. MARKET BY APPLICATION
    • ORTHOPEDIC SURGERY
    • CARDIO AND THORACIC SURGERY
    • NEURO AND SPINE SURGERY
    • GENERAL SURGERY
    • OTHER APPLICATIONS
  4. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • GERMANY
        • UNITED KINGDOM
        • FRANCE
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • AUSTRALIA & NEW ZEALAND
        • SOUTH KOREA
        • THAILAND
        • INDONESIA
        • VIETNAM
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    Choose License Type

    Buy Now